Anti-tumor immune response in early stage non small cell lung cancer (NSCLC): implications for adjuvant therapy

بواسطة Butts, Charles A.
الحاوية / القاعدة Transl Lung Cancer Res (2013)

Adjuvant Therapy in Non-Small Cell Lung Cancer: Current and Future Directions

بواسطة Sangha, Randeep, Price, Julie, Butts, Charles A.
منشور في 2010

Uptake and Tolerance of Chemotherapy in Elderly Patients with Small Cell Lung Cancer and Impact on Survival

بواسطة Fisher, Stacey, Al-Fayea, Turki M., Winget, Marcy, Gao, He, Butts, Charles
منشور في 2012

Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma

بواسطة Bigam David, Butts Charles, Dixon Elijah, Sutherland Francis, Dowden Scot, Bathe Oliver F, Walley Barb, Ruether Dean, Ernst Scott
منشور في 2004-07-01

Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma

بواسطة Bathe, Oliver F, Dowden, Scot, Sutherland, Francis, Dixon, Elijah, Butts, Charles, Bigam, David, Walley, Barb, Ruether, Dean, Ernst, Scott
منشور في 2004

A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases

بواسطة Bathe, Oliver F, Ernst, Scott, Sutherland, Francis R, Dixon, Elijah, Butts, Charles, Bigam, David, Holland, David, Porter, Geoffrey A, Koppel, Jennifer, Dowden, Scot
منشور في 2009

Rapid atrophy of cardiac left ventricular mass in patients with non‐small cell carcinoma of the lung

بواسطة Kazemi‐Bajestani, Seyyed Mohammad Reza, Becher, Harald, Butts, Charles, Basappa, Naveen S., Smylie, Michael, Joy, Anil Abraham, Sangha, Randeep, Gallivan, Andrea, Kavsak, Peter, Chu, Quincy, Baracos, Vickie E.
الحاوية / القاعدة J Cachexia Sarcopenia Muscle (2019)

Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non–Small-Cell Lung Cancer: Updated Survival Analysis of J...

بواسطة Butts, Charles A., Ding, Keyue, Seymour, Lesley, Twumasi-Ankrah, Philip, Graham, Barbara, Gandara, David, Johnson, David H., Kesler, Kenneth A., Green, Mark, Vincent, Mark, Cormier, Yvon, Goss, Glenwood, Findlay, Brian, Johnston, Michael, Tsao, Ming-Sound, Shepherd, Frances A.
منشور في 2010

Biomarker analysis of the phase 3 TORCH trial for first line erlotinib versus chemotherapy in advanced non-small cell lung cancer patients

بواسطة Kim, Lucia, Saieg, Mauro, Di Maio, Massimo, Gallo, Ciro, Butts, Charles, Ciardiello, Fortunato, Feld, Ronald, Cheng, Dengxiao, Gebbia, Vittorio, Burgio, Marco Angelo, Alam, Yasmin, Signoriello, Simona, Rossi, Antonio, Leighl, Natasha, Maione, Paolo, Morabito, Alessandro, Liu, Geoffrey, Tsao, Ming-Sound, Perrone, Francesco, Gridelli, Cesare
الحاوية / القاعدة Oncotarget (2017)

Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study

بواسطة Goss, Glenwood D., O'Callaghan, Chris, Lorimer, Ian, Tsao, Ming-Sound, Masters, Gregory A., Jett, James, Edelman, Martin J., Lilenbaum, Rogerio, Choy, Hak, Khuri, Fadlo, Pisters, Katherine, Gandara, David, Kernstine, Kemp, Butts, Charles, Noble, Jonathan, Hensing, Thomas A., Rowland, Kendrith, Schiller, Joan, Ding, Keyue, Shepherd, Frances A.
منشور في 2013

Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis

بواسطة Antonia, Scott J, Borghaei, Hossein, Ramalingam, Suresh S, Horn, Leora, De Castro Carpeño, Javier, Pluzanski, Adam, Burgio, Marco A, Garassino, Marina, Chow, Laura Q M, Gettinger, Scott, Crinò, Lucio, Planchard, David, Butts, Charles, Drilon, Alexander, Wojcik-Tomaszewska, Joanna, Otterson, Gregory A, Agrawal, Shruti, Li, Ang, Penrod, John R, Brahmer, Julie
الحاوية / القاعدة Lancet Oncol (2019)

Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial

بواسطة Wakelee, Heather A., Dahlberg, Suzanne E., Keller, Steven M., Tester, William J., Gandara, David R., Graziano, Stephen L., Adjei, Alex, Leighl, Natasha B., Aisner, Seena C., Rothman, Jan M., Patel, Jyoti D., Sborov, Mark D., McDermott, Sean R., Perez-Soler, Roman, Traynor, Anne M., Butts, Charles, Evans, Tracey, Shafqat, Atif, Chapman, Andrew E., Kasbari, Samer S., Horn, Leora, Ramalingam, Suresh S., Schiller, Joan
الحاوية / القاعدة Lancet Oncol (2017)

Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer

بواسطة Borghaei, Hossein, Gettinger, Scott, Vokes, Everett E., Chow, Laura Q. M., Burgio, Marco Angelo, de Castro Carpeno, Javier, Pluzanski, Adam, Arrieta, Oscar, Frontera, Osvaldo Arén, Chiari, Rita, Butts, Charles, Wójcik-Tomaszewska, Joanna, Coudert, Bruno, Garassino, Marina Chiara, Ready, Neal, Felip, Enriqueta, García, Miriam Alonso, Waterhouse, David, Domine, Manuel, Barlesi, Fabrice, Antonia, Scott, Wohlleber, Markus, Gerber, David E., Czyzewicz, Grzegorz, Spigel, David R., Crino, Lucio, Eberhardt, Wilfried Enst Erich, Li, Ang, Marimuthu, Sathiya, Brahmer, Julie
الحاوية / القاعدة J Clin Oncol (2021)